| Identification | More | [Name]
4-(Bromoacetyl)pyridine hydrobromide | [CAS]
5349-17-7 | [Synonyms]
2-BROMO-1-(4-PYRIDINYL)-1-ETHANONE HYDROBROMIDE
2-BROMO-1-PYRDIN-4-YLETHAN-1-ONE HYDROBROMIDE
4-(2-BROMO-ACETYL)-PYRIDINIUM, BROMIDE
4-(BROMOACETYL)PYRIDINE HYDROBROMIDE
BUTTPARK 37\12-45
2-Bromo-1-pyridin-4-ylethanone hydrobromide
2-Bromo-1-pyrdin-3-ylethan-1-one hydrobromide
2-Bromo-1-(pyridin-4-yl)ethan-1-one hydrobromide
4-( Bromoacetyl)pyridine
ETHANONE,2-BROMO-1-(4-PYRIDINYL)-,HYDROBROMIDE | [EINECS(EC#)]
621-664-3 | [Molecular Formula]
C7H7Br2NO | [MDL Number]
MFCD02681893 | [Molecular Weight]
280.94 | [MOL File]
5349-17-7.mol |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection .
S37/39:Wear suitable gloves and eye/face protection . | [Hazard Note ]
Irritant | [HazardClass ]
8 |
| Hazard Information | Back Directory | [Uses]
Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase 4-(Bromoacetyl)pyridine hydrobromide was used to prepare 2-Phenyl-4-(4-pyridyl)imidazole. |
|
|